Evidence map›Paper›PMID 35948979›Full record

ArticleMolecular cancer2022

Correction: Neurotensin promotes the progression of malignant glioma through NTSR1 and impacts the prognosis of glioma patients.

Qing Ouyang, Xueyang Gong, Hualiang Xiao, Ji Zhou, Minhui Xu, Yun Dai, Lunshan Xu, Hua Feng, Hongjuan Cui, Liang Yi

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Qing Ouyang *Department of Neurosurgery, Daping Hospital, Third Military Medical University, Chongqing, China.
Xueyang Gong *State Key Laboratory of Silkworm Genome Biology, Institute of Sericulture and Systems Biology, Southwest University, Chongqing, China.
Hualiang Xiao *Department of Pathology, Daping Hospital, Third Military Medical University, Chongqing, China.
Ji ZhouDepartment of Neurosurgery, Daping Hospital, Third Military Medical University, Chongqing, China.
Minhui XuDepartment of Neurosurgery, Daping Hospital, Third Military Medical University, Chongqing, China.
Yun DaiDivision of Hematology/Oncology, Department of Medicine, Virginia Commonwealth University, Richmond, VA, USA.
Lunshan XuDepartment of Neurosurgery, Daping Hospital, Third Military Medical University, Chongqing, China.
Hua FengDepartment of Neurosurgery, Southwest Hospital, Third Military Medical University, Chongqing, China.
Hongjuan CuiState Key Laboratory of Silkworm Genome Biology, Institute of Sericulture and Systems Biology, Southwest University, Chongqing, China. hongjuan.cui@gmail.com.
Liang YiDepartment of Neurosurgery, Daping Hospital, Third Military Medical University, Chongqing, China. happyape@126.com.
Army Medical University · CNDaping Hospital · CNSouthwest Hospital · CNSouthwest University · CNState Key Laboratory of Silkworm Genomic BiologyVirginia Commonwealth University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35948979
PMCPMC9364496
OpenAlexW4291019950

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.